1.25 DIHYDROXY-VITAMIN D5 (1.25 (OH), vit D3) IN THE TREATMENT OF IDIOPATHIC MYELOFIBROSIS
Open Access
- 1 August 1987
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 66 (4) , 579-580
- https://doi.org/10.1111/j.1365-2141.1987.tb01348.x
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- THE ROLE OF 1,25‐DIHYDROXY‐VITAMIN D3 (1,25(OH)2D3) IN THE TREATMENT OF IDIOPATHIC MYELOFIBROSISBritish Journal of Haematology, 1987
- CLINICAL AND LABORATORY STUDIES OF 1,25-DIHYDROXYCHOLECALCIFEROL IN MYELOFIBROSISBritish Journal of Haematology, 1987
- 1,25‐DIHYDROXY‐VITAMIN D3 (1,25(OH)2D3) IN THE TREATMENT OF 1DIOPATHIC MYELOFIBROSISBritish Journal of Haematology, 1986
- THE USEFULNESS OF 1,25‐DIHYDROXY‐VITAMIN D3 (1,25(OH)2 vit D3) IN THE TREATMENT OF IDIOPATHIC MYELOFIBROSISBritish Journal of Haematology, 1986
- CLINICAL EVIDENCE FOR 1,25-HYDROXYCHOLECALCIFEROL ACTION IN MYELOFIBROSISThe Lancet, 1984
- A ROLE FOR 1,25-DIHYDROXYVITAMIN D3 IN CONTROL OF BONE-MARROW COLLAGEN DEPOSITION?The Lancet, 1984